Oropharyngeal Carcinoma — Trials

Oropharyngeal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

297 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 107
Recruiting: 56
Ph III recruiting: 3
Growth YoY: −13.6%
Industry share: 8%
Top sponsor: National Cancer Institute (NCI)
Termination share: 39.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (47)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04140513	Digital PET Scan for the Prediction of Outcomes in Patients With Locally Advanced Oropharyngeal Cancer	withdrawn	N/A	0	Ohio State University Comprehensive Cancer CenterOTHER	1	Mar 8, 2024	clinicaltrials
NCT03611205	Interim Digital PET/CT in Predicting Outcomes for Participants With Locally Advanced Oropharyngeal Cancer Undergoing Chemoradiation Therapy	withdrawn	N/A	0	Ohio State University Comprehensive Cancer CenterOTHER	0	Aug 7, 2019